<DOC>
	<DOCNO>NCT01486056</DOCNO>
	<brief_summary>This prospective , unblinded , non-randomized , descriptive study design collect ECG data .</brief_summary>
	<brief_title>ECG Vector Determination</brief_title>
	<detailed_description>This prospective , unblinded , non-randomized , descriptive study design collect ECG data determine process proper generator lead placement . The study conduct two phase : Phase I include ECG data collection human subject ; Phase II , Implant Instructions Use evaluate Cyberonics ' Clinical Engineers base activity five eight experience VNS surgeon .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>1 . At least 12 year old general good health Phase I . At least 18 year old general good health Phase II . 2 . Patients guardian must willing provide sign informed consent/assent HIPAA authorization . Note : Patients diagnose epilepsy take least 1 antiepileptic medication desire require study . 1 . History pathologically significant cardiac arrhythmia include limited atrial fibrillation flutter , chronotropic incompetence , supraventricular tachycardia , ventricular flutter fibrillation , implantation permanent cardiac pacemaker defibrillator . 2 . Currently present exist sign skin irritation rash leave neck upper left chest determine PI . 3 . History physical adverse reaction adhesive electrode .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>ECG</keyword>
	<keyword>device placement</keyword>
</DOC>